About the journal

Cobiss

Srpski arhiv za celokupno lekarstvo 2016 Volume 144, Issue 11-12, Pages: 597-601
https://doi.org/10.2298/SARH1612597R
Full text ( 167 KB)


Is pacemaker therapy the right key to patients with vasovagal syncope?

Radovanović Nikola N. (Clinical Center of Serbia, Pacemaker Center, Belgrade)
Kirćanski Bratislav (Clinical Center of Serbia, Pacemaker Center, Belgrade)
Raspopović Srđan (Clinical Center of Serbia, Pacemaker Center, Belgrade)
Pavlović Siniša U. ORCID iD icon (Clinical Center of Serbia, Pacemaker Center, Belgrade + School of Medicine, Belgrade)
Jovanović Velibor (Clinical Center of Serbia, Pacemaker Center, Belgrade)
Milašinović Goran (Clinical Center of Serbia, Pacemaker Center, Belgrade + School of Medicine, Belgrade)

Introduction. Vasovagal syncope is the most common type of reflex syncope. Efficacy of cardiac pacing in this indication has not been the subject of many studies and pacemaker therapy in patients with vasovagal syncope is still controversial. Objective. This study aimed to assess the efficacy and safety of pacing therapy in treatment of patients with vasovagal syncope, to determine contribution of new therapeutic models in increasing its success, and to identify risk factors associated with a higher rate of symptoms after pacemaker implantation. Methods. A retrospective study included 30 patients with pacemaker implanted due to vasovagal syncope in the Pacemaker Center, Clinical Center of Serbia, between November 2003 and June 2014. Head-up tilt test was performed to diagnose vasovagal syncope. Patients with cardioinhibitory and mixed type of disease were enrolled in the study. Results. Mean age was 48.1 ± 11.1 years and 18 (60%) patients were men. Mean follow-up period was 5.9 ± 3.0 years. Primarily, implantable loop recorder was implanted in 10 (33.3%) patients. Twenty (66.7%) patients presented cardioinhibitory and 10 (33.3%) mixed type of vasovagal syncope. After pacemaker implantation, 11 (36.7%) patients had syncope. In multiple logistic regression analysis we showed that syncope is statistically more likely to occur after pacemaker implantation in patients with mixed type of vasovagal syncope (p = 0.018). There were two (6.7%) perioperative surgical complications. Conclusion. Pacemaker therapy is a safe treatment for patients with vasovagal syncope, whose efficacy can be improved by strict selection of patients. We showed that symptoms occur statistically more often in patients with mixed type of disease after pacemaker implantation.

Keywords: vasovagal syncope, pacemaker therapy, head-up tilt test